Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
P Wang, Q Song, J Ren, W Zhang, Y Wang… - Science translational …, 2022 - science.org
Cell-free DNA (cfDNA)–based liquid biopsy is a promising approach for the early detection
of cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use …
of cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use …
[PDF][PDF] Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
P Wang, Q Song, J Ren, W Zhang, Y Wang, L Zhou… - 2022 - apostlebio.com
Hepatocellular carcinoma (HCC) is the fifth most common and the third most lethal cancer
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
P Wang, Q Song, J Ren, W Zhang… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
Cell-free DNA (cfDNA)-based liquid biopsy is a promising approach for the early detection of
cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use of …
cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use of …
[PDF][PDF] Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
P Wang, Q Song, J Ren, W Zhang, Y Wang, L Zhou… - 2022 - researchgate.net
Hepatocellular carcinoma (HCC) is the fifth most common and the third most lethal cancer
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
[PDF][PDF] Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection
P Wang, Q Song, J Ren, W Zhang, Y Wang, L Zhou… - 2022 - cn.apostlebio.com
Hepatocellular carcinoma (HCC) is the fifth most common and the third most lethal cancer
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
worldwide (1). The 5-year survival rate for advanced-stage HCC is only 12% because the …
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
P Wang, Q Song, J Ren, W Zhang… - Science …, 2022 - search.ebscohost.com
Abstract Cell-free DNA (cfDNA)–based liquid biopsy is a promising approach for the early
detection of cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting …
detection of cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting …
Simultaneous analysis of mutations and methylations in circulating cell-free DNA for hepatocellular carcinoma detection.
P Wang, Q Song, J Ren, W Zhang, Y Wang… - Science Translational …, 2022 - europepmc.org
Cell-free DNA (cfDNA)-based liquid biopsy is a promising approach for the early detection of
cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use of …
cancer. A major hurdle is the limited yield of cfDNA from one blood draw, limiting the use of …